Optipharm.CO.LTD (153710) — Financial Flexibility Index
Optipharm.CO.LTD (153710) has a Financial Flexibility Index of -0.01x as of December 2025. Free cash flow of ₩-97.44 Million (operating CF ₩-408.70 Million minus capex ₩311.27 Million) represents 0% of total liabilities (₩15.37 Billion). Also explore 153710 net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Optipharm.CO.LTD Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Optipharm.CO.LTD across 11 annual periods. Check 153710 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Optipharm.CO.LTD (2015–2025)
Year-by-year free cash flow to debt coverage for Optipharm.CO.LTD. For the full company profile including market capitalisation, see how much is Optipharm.CO.LTD worth.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | ₩990.05 Million | ₩-1.55 Billion | ₩15.37 Billion | ▼ -9.7% |
| 2024 | 0.07x | ₩1.14 Billion | ₩-595.50 Million | ₩15.98 Billion | ▲ +6829.7% |
| 2023 | 0.00x | ₩14.55 Million | ₩-1.72 Billion | ₩14.13 Billion | ▼ -99.4% |
| 2022 | 0.18x | ₩2.17 Billion | ₩-2.43 Billion | ₩12.17 Billion | ▲ +250.2% |
| 2021 | -0.12x | ₩-1.21 Billion | ₩-1.97 Billion | ₩10.21 Billion | ▼ -23.3% |
| 2020 | -0.10x | ₩-725.76 Million | ₩-1.62 Billion | ₩7.54 Billion | ▼ -154.8% |
| 2019 | 0.18x | ₩1.07 Billion | ₩447.47 Million | ₩6.11 Billion | ▼ -10.1% |
| 2018 | 0.20x | ₩1.41 Billion | ₩1.20 Billion | ₩7.20 Billion | ▲ +48.1% |
| 2017 | 0.13x | ₩931.19 Million | ₩260.86 Million | ₩7.06 Billion | ▼ -25.5% |
| 2016 | 0.18x | ₩1.25 Billion | ₩861.36 Million | ₩7.08 Billion | ▲ +479.7% |
| 2015 | -0.05x | ₩-611.90 Million | ₩-751.51 Million | ₩13.12 Billion | — |